Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
Marianna Fontana, John L. Berk, Julian D. Gillmore, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
Marianna Fontana, Scott D. Solomon, Jessica Kachadourian, et al.
New England Journal of Medicine (2024) Vol. 391, Iss. 23, pp. 2231-2241
Closed Access | Times Cited: 21
The Last Decade in Cardiac Amyloidosis
Alberico Del Torto, Adam Ioannou, Sarah Cuddy, et al.
JACC. Cardiovascular imaging (2025)
Open Access | Times Cited: 3
Artificial intelligence-guided detection of under-recognised cardiomyopathies on point-of-care cardiac ultrasonography: a multicentre study
Evangelos K. Oikonomou, Akhil Vaid, Gregory Holste, et al.
The Lancet Digital Health (2025) Vol. 7, Iss. 2, pp. e113-e123
Closed Access | Times Cited: 3
Suspicion and referral of patients with transthyretin amyloid cardiomyopathy: Recommendations by a Portuguese multidisciplinary expert panel
Dulce Brito, J R Agostinho, Carlos Aguíar, et al.
Revista Portuguesa de Cardiologia (2025) Vol. 44, pp. 59-68
Open Access | Times Cited: 3
Transthyretin amyloid cardiomyopathy: a paradigm for advancing precision medicine
Esther Gonzalez-Lopez, Mathew S. Maurer, Pablo García‐Pavía
European Heart Journal (2025)
Open Access | Times Cited: 2
Transthyretin Cardiac Amyloidosis: Current and Emerging Therapies
Aalpen A. Patel, Pengyang Li, Narotham Badrish, et al.
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 2
A Multicenter Study of Contemporary Long-Term Tafamidis Outcomes in Transthyretin Amyloid Cardiomyopathy
Ahmad Masri, Priyanka Bhattacharya, Brent Medoff, et al.
JACC CardioOncology (2025)
Open Access | Times Cited: 2
Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy
Daniel P. Judge, Kevin Alexander, Francesco Cappelli, et al.
Journal of the American College of Cardiology (2025) Vol. 85, Iss. 10, pp. 1003-1014
Open Access | Times Cited: 2
Coprevalence of Amyloidosis and Aortic Stenosis: When to Screen and Who to Treat?
Brett W. Sperry
Journal of the American Heart Association (2025)
Open Access | Times Cited: 1
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration
Aldostefano Porcari, Yousuf Razvi, Francesco Cappelli, et al.
JAMA Cardiology (2025)
Closed Access | Times Cited: 1
Can Outpatient Worsening Heart Failure Serve as an Endpoint in Clinical Trials of Transthyretin Amyloidosis?
Richard K. Cheng, Douglas Leedy, Frederick L. Ruberg
Journal of the American College of Cardiology (2025)
Closed Access | Times Cited: 1
Expanding the Genetic and Clinical Spectrum of Hereditary Transthyretin Amyloidosis: The Glu61Ala Variant
Calogero Messina, Salvatore Gulizia, Federica Scalia, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 2, pp. 61-61
Open Access | Times Cited: 1
Translation of genomics into routine cardiological practice: insights from a European Society of Cardiology Cardiovascular Round Table
Stefanie Dimmeler, Leticia Ferri, Paul Nioi, et al.
European Heart Journal (2025)
Closed Access | Times Cited: 1
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Takeshi Kitai, Shun Kohsaka, Takao Kato, et al.
Journal of Cardiac Failure (2025)
Closed Access | Times Cited: 1
Therapeutic effect of TTR siRNA on hereditary transthyretin amyloidosis (ATTRv) nephropathy
Takahiro Ajiki, Tatsuhiko Ozono, Fusako Sera, et al.
Amyloid (2025), pp. 1-8
Closed Access
Outpatient Worsening Heart Failure in Patients with Transthyretin Amyloidosis with Cardiomyopathy in the HELIOS-B Trial
Alberico Del Torto, Matthew J. Maurer, Julian D. Gillmore, et al.
Journal of the American College of Cardiology (2024)
Open Access | Times Cited: 4
Vutrisiran for ATTR Amyloidosis with Cardiomyopathy
Giampaolo Merlini
New England Journal of Medicine (2025) Vol. 392, Iss. 1, pp. 83-84
Closed Access
The JCF 2024 Year-In-Review
Jennifer Maning, Anuradha Lala, Robert J. Mentz
Journal of Cardiac Failure (2025) Vol. 31, Iss. 1, pp. 1-3
Closed Access
New therapies to treat cardiac amyloidosis
O.T.D. Nguyen, Daniel Kamna, Ahmad Masri
Current Opinion in Cardiology (2025) Vol. 40, Iss. 2, pp. 98-106
Closed Access
A Critical Time for Tafamidis in the Real World – Will the Data Support its First Mover Advantage?
Paloma Remior Pérez, Sumeet S. Mitter
Journal of Cardiac Failure (2025)
Closed Access
The Accuracy of Technetium-99 m Pyrophosphate Imaging in Diagnosing Transthyretin Cardiac Amyloidosis and Its Impact on Patient Management
Zainab Altaha, Robert J.H. Miller
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access
Multifaceted pulmonary manifestations of amyloidosis: state-of-the-art update
Antonios Charokopos, Misbah Baqir, Anja C. Roden, et al.
Expert Review of Respiratory Medicine (2025), pp. 1-14
Closed Access
Improving Long-term Outcomes in ATTR-CM
Nowell M. Fine
JACC CardioOncology (2025) Vol. 7, Iss. 3, pp. 294-296
Open Access
A Question in the Era of Multiple Effective Therapies for Transthyretin Amyloid Cardiomyopathy (ATTR-CM): Is Transthyretin Biology a Driver of Disease Progression?
Matthew J. Maurer
Journal of Cardiac Failure (2025)
Closed Access
Hereditary Transthyretin Amyloidosis (ATTRv)
Filippos Triposkiadis, Αlexandros Briasoulis, Randall C. Starling, et al.
Current Problems in Cardiology (2025), pp. 103019-103019
Closed Access
Page 1 - Next Page

Scroll to top